Legal Representation
Attorney
Law Offices of Charles L. Thoeming
USPTO Deadlines
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 4, 2013 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 4, 2013 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 11, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 10, 2012 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 5, 2012 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 9, 2012 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Jul 7, 2012 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Jul 7, 2012 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jul 7, 2012 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Dec 16, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 14, 2011 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 14, 2011 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 14, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 5, 2011 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 10, 2011 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 10, 2011 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 7, 2011 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Apr 1, 2011 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 29, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 28, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 28, 2011 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Mar 24, 2011 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 24, 2011 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Mar 24, 2011 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Mar 8, 2011 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Mar 3, 2011 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Mar 3, 2011 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Mar 2, 2011 | INCD | O | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST | Loading... |
| Mar 1, 2011 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 28, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 28, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 16, 2011 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 8, 2011 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 24, 2010 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 24, 2010 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 24, 2010 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 22, 2010 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 20, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 18, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; and Pharmaceutical skin lotions
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Other
The name(s), portrait(s), and/or signature(s) shown in the mark identifies Allen "Baron", whose consent(s) to register is made of record.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BRAND"